Experimental T-Cell therapy for liver cancer shows early promise but trial halted
NCT ID NCT04502082
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-stage trial tested a new treatment called ET140203 T cells for adults with advanced liver cancer that had not responded to other therapies. The treatment uses a patient's own immune cells, modified to target cancer cells. The study was stopped early after enrolling only 8 people, and its main goal was to check safety and find the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Kansas University Medical Center
Westwood, Kansas, 66205, United States
Conditions
Explore the condition pages connected to this study.